BMRN
Biomarin Pharmaceutical Inc
61.40$
-1.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +341.7% | +83.3% | +20.4% | +19.0% | -13.1% | +54.1% | +37.7% | +228.1% | +44.4% | +143.9% | +9.5% | +15.9% | +17.3% | +13.5% | +9.5% | +36.6% | +18.8% | +25.5% | +17.6% | +13.5% | +14.3% | +9.2% | -0.8% | +13.5% | +15.4% | +18.0% | +12.9% | |
| – | – | – | – | +40.1% | -3.1% | -93.6% | -33.5% | +232.4% | +110.1% | +186.0% | +25.5% | +6.6% | +19.5% | +9.3% | -3.7% | +38.3% | +24.3% | +37.9% | +15.3% | +30.4% | +14.0% | +45.8% | -10.3% | +6.9% | +5.8% | +9.1% | +27.0% | |
| – | +587.9% | +44.9% | -38.2% | +19.0% | -13.1% | +21.4% | +56.9% | +227.6% | +36.8% | +136.4% | +6.1% | +18.3% | +16.8% | +14.4% | +12.5% | +36.3% | +17.7% | +23.0% | +18.1% | +9.7% | +14.3% | -0.6% | +3.0% | +15.8% | +18.5% | +20.5% | +9.3% | |
| – | +159.1% | +31.6% | +26.5% | +20.3% | +0.7% | -9.2% | +13.3% | +18.3% | +17.8% | +18.7% | +23.4% | +28.0% | +45.5% | +41.0% | +17.4% | +30.1% | +37.5% | +4.3% | -7.7% | +14.0% | +2.7% | -12.2% | +0.1% | +3.3% | +15.0% | +0.1% | +23.4% | |
| – | +94.4% | +29.5% | -23.8% | +161.1% | -17.9% | +161.2% | +10.5% | +18.0% | +58.1% | +37.4% | +16.6% | +22.1% | +15.6% | +13.0% | +18.8% | +28.4% | +33.1% | +18.5% | +16.3% | -49.5% | +6.6% | +11.9% | +6.0% | +5.2% | +8.3% | +31.8% | +116.6% | |
| – | +151.3% | +39.8% | +36.5% | +30.7% | -5.2% | +120.8% | -55.0% | +14.8% | +60.3% | +27.2% | +18.7% | +26.0% | +28.1% | +32.7% | +18.7% | +16.8% | +17.9% | +101.6% | -36.5% | +19.6% | +11.2% | -4.5% | +5.7% | -1.8% | +18.8% | +5.2% | +9.0% | |
| – | – | – | – | – | – | – | – | – | – | – | -58.7% | -96.7% | -6,329.8% | – | – | – | – | – | – | – | – | – | – | – | +15.4% | +160.6% | +10.2% | |
| – | – | – | -100.0% | – | +477.7% | +236.8% | +13.0% | +40.3% | -14.8% | +15.1% | -14.1% | -26.7% | -19.2% | -8.5% | +36.8% | +250.7% | +4.4% | +3.3% | +8.1% | +2.2% | -46.3% | +24.9% | -47.7% | +4.1% | +8.5% | -26.9% | -14.0% | |
| – | – | – | – | – | – | – | – | – | – | – | -98.3% | -3,896.8% | – | – | – | – | – | – | – | – | – | – | – | – | +26.1% | +187.3% | -10.9% | |
| – | – | +661.4% | +357.7% | -50.7% | -100.1% | – | -40.1% | +5.7% | -96.8% | +255.7% | -59.4% | -21,666.3% | – | -138.5% | – | – | +87.6% | -1,276.2% | – | -180.7% | – | – | – | – | +161.0% | +449.3% | +16.3% | |
| – | – | – | – | – | – | – | – | – | – | – | -101.6% | – | -126.2% | – | – | – | – | – | – | – | – | – | -107.5% | – | +18.4% | +154.6% | -18.3% | |
| – | – | – | – | – | – | – | – | – | – | – | -47.2% | -52.1% | -101.0% | – | – | – | – | – | – | -103.7% | – | +162.1% | -43.3% | +459.4% | +15.6% | +112.1% | -11.9% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.